companydata.dkcompanydata.dk

INNZ MEDICAL ApS: Financial statements 2022

CVR: 34490805

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

INNZ MEDICAL ApS (CVR 34490805) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,649,545 and a net result of DKK 572,273 compared with DKK 616,252 the year before. That is an increase of 6.3% compared with the year before. Equity in the 2022 report amounted to DKK 837,065. The solvency ratio was 21%. The company had 4 employees in the financial year.

Gross Profit
DKK 3,649,545
Profit/Loss
DKK 572,273
Equity
DKK 837,065
Total Assets
DKK 3,990,226
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-3.6M572K837K4
2021-3.4M616K865K4
2020-2.5M-23K249K4
2019-2.2M78K271K4
2018-1.6M91K194K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on INNZ MEDICAL ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

INNZ MEDICAL ApS: The 2021 annual report is outMay 5, 2022

INNZ MEDICAL ApS has published its annual report for 2021. Gross profit came to DKK 3,433,630, and the net result was DKK 616,252.

About INNZ MEDICAL ApS

INNZ MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hobro, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dheeraj Bansal and Steen Hansen. The company is owned by Bansal Group AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 2,573,854 and a net result of DKK -708,583 compared with DKK -273,008 the year before. Equity in the 2025 report amounted to DKK -737,476.

Source: annual report 2025, Danish Business Authority